Clinical trials in the Commonwealth of the Independent States
The Commonwealth of the Independent States (CIS) is a union of post-Soviet countries, which aims to maintain economic benefits established between the former members of the USSR, while they were a single state. The CIS include Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyzstan, Moldova, Russia, Tajikistan, and Uzbekistan. Smooth Drug Development offers clinical trials services in the CIS.
Smooth Drug Development helps Sponsors to utilize unique advantages of the CIS countries and offer full-cycle clinical trials services, guided by the highest quality standards. Smooth Drug Development is dedicated to quality control and holds ISO 9001:2015 certificate in “Quality Management System.” The Smooth QMS reaches out to each and every aspect of our activity. Hence, Smooth Drug Development guarantees strict control over the clinical trials in the CIS countries.
Smooth Drug Development makes research in the CIS fast and cost-effective and guarantees the highest quality.